Insiders Biostax Corp.

Equities

Market Closed - OTC Markets Other stock markets 10:49:43 2024-05-29 am EDT			5-day change	1st Jan Change
0.035 ^USD	+6.06%		-2.78%	-52.05%

May. 20	Biostax Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 16	Biostax Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Biostax Corp. Appoints Craig Suro as a Director	Nov. 15	CI
Biostax Corp. Appoints Mary Clay Caperton to its Board of Directors	Nov. 02	CI
Immune Therapeutics, Inc. will Change its Name to Biostax Corp	23-10-05	CI
Immune Therapeutics, Inc. Announces CEO Changes	23-09-13	CI
Immune Therapeutics, Inc. Announces Management Changes	23-09-13	CI
Immune Therapeutics, Inc. Announces Director Resignations	23-01-03	CI
Immune Therapeutics, Inc. Announces Executive Changes	22-11-09	CI
Immune Therapeutics, Inc. Announces CEO Changes	22-11-09	CI
Immune Therapeutics, Inc. Appoints H. Louis Salomonksy to Its Board of Directors	22-09-27	CI
Immune Therapeutics, Inc. Announces the Appointment of Glen Farmer as Chief Financial Officer	22-08-04	CI
Immune Therapeutics, Inc. Announces the Appointment of Kelly O’Brien Wilson as Chief Operating Officer	22-08-04	CI
Immune Therapeutics, Inc. Announces Executive Changes	22-07-22	CI
Immune Therapeutics, Inc. Announces Chief Executive Officer Changes	22-07-22	CI
Immune Therapeutics, Inc. Announces Board Changes	22-06-03	CI
Immune Therapeutics, Inc. Announces the Resignation of Michael Sander as a Director	21-01-26	CI
Immune Therapeutics, Inc. Appoints Kevin J. Phelps as CEO	20-07-27	CI
Immune Therapeutics, Inc. Appoints Kevin J. Phelps as President	20-07-27	CI
Immune Therapeutics, Inc. Announces Management Changes	20-05-05	CI
Immune Therapeutics, Inc. Announces Executive Changes	20-02-18	CI
Immune Therapeutics, Inc. Appoints Dr. Robert Buckheit, Jr. to the Scientific Advisory Board	19-10-22	CI

No results for this search